slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 89,731-89,760
Pages 3,685
Rows per page 30
Component
89,731-89,760 of 110,539
55
The slide explains the drivers behind the margin compression, specifically mentioning the Video vertical, staff/technical costs, inflation, and Russia-related transaction costs.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
56
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
58
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
59
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
60
Includes a break in the x-axis between FY25e and FY27e.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
61
The map illustrates the complementary nature of GEO (targeted high-demand areas) and LEO (global coverage) satellite networks.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
62
The slide uses a causal flow from technical capabilities (left) to strategic benefits (right).Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
64
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
65
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
04
The slide uses a dual-track timeline (Pipeline Progress vs Platform/Corporate) followed by a list of future goals.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Situation & Context1 hit
05
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
16
The slide uses a process flow diagram to illustrate a clinical case study.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Evidence & Proof1 hit
20
The slide highlights the integration of various data sources (Knowledge Graphs, Neural Networks, Literature/Patent Databases, Multi-omics, Vector Embedding) into a unified AI workflow.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
28
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
32
The slide shows a heatmap of 43 patient samples across different cancer types, correlating ABS with signature scores.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
34
The slide uses a combination of bar charts and scatter plots to demonstrate the inverse relationship between ABS and TIS.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
35
The slide presents two line/box plots showing dose-dependent responses to stabilised adenosine.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
36
The slide presents two key clinical data plots: a pharmacodynamic correlation (exposure vs inhibition) and a pharmacokinetic profile (concentration over time).Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
39
The slide uses a human anatomy diagram to map specific cancer types to their respective incidence numbers.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
42
The table uses a color-coded system (green/yellow/red) to indicate performance against criteria.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
43
Data source: Besnard et al, AACR (2022).Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
45
The slide uses a heatmap to display binary synergy results (Yes/No) across three drug combinations, alongside a bar chart showing single-agent sensitivity.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
53
Includes two scientific diagrams illustrating the mechanism of action and brain penetration.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
55
The slide uses a traffic-light color coding system to indicate performance against criteria.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
57
The slide uses a Pareto front to illustrate the trade-off between CNS score and Potency, highlighting the selection of 'unattractive' compounds.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
59
The slide uses two distinct chart types (dot plot and line chart) to demonstrate the safety profile of a reversible inhibitor.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
60
The chart shows a statistically significant difference (****) between the vehicle control and the treatment groups.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
65
Scientific/medical context slide explaining a therapeutic target.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
67
The slide uses a scientific mechanism-of-action argument to establish a competitive moat.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
70
The image shows a protein binding site with color-coded regions (Donor, Apolar, Acceptor) indicating chemical properties.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit